Number of respondents by (selected*) first cancer site and date of diagnosis: Fee-For-Service

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 35,812 9,395 26.23 5,206 14.54 5,785 16.15 8,582 23.96 6,844 19.11
Breast 34,571 10,286 29.75 4,361 12.61 4,982 14.41 7,026 20.32 7,916 22.90
Colorectal 17,915 7,109 39.68 2,565 14.32 2,379 13.28 3,011 16.81 2,851 15.91
Lung and Bronchus 17,245 12,241 70.98 2,187 12.68 1,210 7.02 1,064 6.17 543 3.15
Melanoma Skin 13,634 5,016 36.79 1,918 14.07 1,956 14.35 2,375 17.42 2,369 17.38
Bladder 10,348 4,511 43.59 1,549 14.97 1,394 13.47 1,617 15.63 1,277 12.34
Non-Hodgkins Lymphoma 7,244 3,247 44.82 1,038 14.33 979 13.51 1,149 15.86 831 11.47
Uterine Corpus 6,016 1,798 29.89 731 12.15 787 13.08 1,151 19.13 1,549 25.75
Kidney/Renal Pelvis 5,284 2,302 43.57 746 14.12 726 13.74 869 16.45 641 12.13
Head/Neck 4,834 1,970 40.75 694 14.36 671 13.88 788 16.30 711 14.71
Leukemia 4,532 2,345 51.74 656 14.47 523 11.54 623 13.75 385 8.50
Pancreas 3,267 2,792 85.46 280 8.57 84 2.57 71 2.17 40 1.22
Ovary 2,046 938 45.85 290 14.17 223 10.90 241 11.78 354 17.30
Stomach 2,006 1,271 63.36 243 12.11 161 8.03 192 9.57 139 6.93
Liver/Bile Duct 1,534 1,139 74.25 193 12.58 98 6.39 79 5.15 25 1.63
Esophagus 1,173 798 68.03 161 13.73 90 7.67 77 6.56 47 4.01
Uterine Cervix 688 170 24.71 71 10.32 71 10.32 122 17.73 254 36.92

* Sites reflect most prevalent cancer sites in SEER-CAHPS.

Last Updated: 03 Jun, 2021